These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12719580)

  • 81. Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection.
    Chan KW; Pan R; Costa M; Gorny MK; Wang S; Lu S; Kong XP
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997214
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.
    Kirby KA; Ong YT; Hachiya A; Laughlin TG; Chiang LA; Pan Y; Moran JL; Marchand B; Singh K; Gallazzi F; Quinn TP; Yoshimura K; Murakami T; Matsushita S; Sarafianos SG
    FASEB J; 2015 Jan; 29(1):70-80. PubMed ID: 25351987
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
    Doria-Rose NA; Schramm CA; Gorman J; Moore PL; Bhiman JN; DeKosky BJ; Ernandes MJ; Georgiev IS; Kim HJ; Pancera M; Staupe RP; Altae-Tran HR; Bailer RT; Crooks ET; Cupo A; Druz A; Garrett NJ; Hoi KH; Kong R; Louder MK; Longo NS; McKee K; Nonyane M; O'Dell S; Roark RS; Rudicell RS; Schmidt SD; Sheward DJ; Soto C; Wibmer CK; Yang Y; Zhang Z; ; Mullikin JC; Binley JM; Sanders RW; Wilson IA; Moore JP; Ward AB; Georgiou G; Williamson C; Abdool Karim SS; Morris L; Kwong PD; Shapiro L; Mascola JR
    Nature; 2014 May; 509(7498):55-62. PubMed ID: 24590074
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.
    Andrabi R; Su CY; Liang CH; Shivatare SS; Briney B; Voss JE; Nawazi SK; Wu CY; Wong CH; Burton DR
    Immunity; 2017 Sep; 47(3):524-537.e3. PubMed ID: 28916265
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.
    Stanfield RL; Ghiara JB; Ollmann Saphire E; Profy AT; Wilson IA
    Virology; 2003 Oct; 315(1):159-73. PubMed ID: 14592768
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.
    Li Y; O'Dell S; Walker LM; Wu X; Guenaga J; Feng Y; Schmidt SD; McKee K; Louder MK; Ledgerwood JE; Graham BS; Haynes BF; Burton DR; Wyatt RT; Mascola JR
    J Virol; 2011 Sep; 85(17):8954-67. PubMed ID: 21715490
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.
    Huang J; Kang BH; Pancera M; Lee JH; Tong T; Feng Y; Imamichi H; Georgiev IS; Chuang GY; Druz A; Doria-Rose NA; Laub L; Sliepen K; van Gils MJ; de la Peña AT; Derking R; Klasse PJ; Migueles SA; Bailer RT; Alam M; Pugach P; Haynes BF; Wyatt RT; Sanders RW; Binley JM; Ward AB; Mascola JR; Kwong PD; Connors M
    Nature; 2014 Nov; 515(7525):138-42. PubMed ID: 25186731
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Analysis of a 17-amino acid residue, virus-neutralizing microantibody.
    Heap CJ; Wang Y; Pinheiro TJT; Reading SA; Jennings KR; Dimmock NJ
    J Gen Virol; 2005 Jun; 86(Pt 6):1791-1800. PubMed ID: 15914858
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates.
    Kessler JA; McKenna PM; Emini EA; Chan CP; Patel MD; Gupta SK; Mark GE; Barbas CF; Burton DR; Conley AJ
    AIDS Res Hum Retroviruses; 1997 May; 13(7):575-82. PubMed ID: 9135875
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation.
    Guzzo C; Zhang P; Liu Q; Kwon AL; Uddin F; Wells AI; Schmeisser H; Cimbro R; Huang J; Doria-Rose N; Schmidt SD; Dolan MA; Connors M; Mascola JR; Lusso P
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538178
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Three amino acid residues in the envelope of human immunodeficiency virus type 1 CRF07_BC regulate viral neutralization susceptibility to the human monoclonal neutralizing antibody IgG1b12.
    Nie J; Zhao J; Chen Q; Huang W; Wang Y
    Virol Sin; 2014 Oct; 29(5):299-307. PubMed ID: 25273335
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
    Xiang SH; Farzan M; Si Z; Madani N; Wang L; Rosenberg E; Robinson J; Sodroski J
    J Virol; 2005 May; 79(10):6068-77. PubMed ID: 15857992
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Design of an Escherichia coli expressed HIV-1 gp120 fragment immunogen that binds to b12 and induces broad and potent neutralizing antibodies.
    Bhattacharyya S; Singh P; Rathore U; Purwar M; Wagner D; Arendt H; DeStefano J; LaBranche CC; Montefiori DC; Phogat S; Varadarajan R
    J Biol Chem; 2013 Apr; 288(14):9815-9825. PubMed ID: 23430741
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.
    Chen L; Kwon YD; Zhou T; Wu X; O'Dell S; Cavacini L; Hessell AJ; Pancera M; Tang M; Xu L; Yang ZY; Zhang MY; Arthos J; Burton DR; Dimitrov DS; Nabel GJ; Posner MR; Sodroski J; Wyatt R; Mascola JR; Kwong PD
    Science; 2009 Nov; 326(5956):1123-7. PubMed ID: 19965434
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates.
    Devico A; Silver A; Thronton AM; Sarngadharan MG; Pal R
    Virology; 1996 Apr; 218(1):258-63. PubMed ID: 8615032
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
    Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL
    J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries.
    Ditzel HJ; Parren PW; Binley JM; Sodroski J; Moore JP; Barbas CF; Burton DR
    J Mol Biol; 1997 Apr; 267(3):684-95. PubMed ID: 9126846
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Computational-guided determination of the functional role of 447-52D long CDRH3.
    Kamau E; Bonneau R; Kong XP
    Protein Eng Des Sel; 2018 Dec; 31(12):479-487. PubMed ID: 31038677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.